These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1783253)

  • 21. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis.
    Wanless IR; Godwin TA; Allen F; Feder A
    Medicine (Baltimore); 1980 Sep; 59(5):367-79. PubMed ID: 7432153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nodular regenerative hyperplasia of the liver with and without portal hypertension: a comparison.
    Harada A; Nakanuma Y; Govindarajan S; Peters RL
    Ann Clin Lab Sci; 1986; 16(2):155-62. PubMed ID: 3963734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation.
    Elariny HA; Mizrahi SS; Hayes DH; Boudreaux JP; Hussey JL; Farr GH
    Transpl Int; 1994 Jul; 7(4):309-13. PubMed ID: 7916934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nodular regenerative hyperplasia of the liver. Study of 15 cases and review of the literature].
    Capron JP; Degott C; Bernuau J; Saint-Marc Girardin MF; Zafrani ES; Braillon A; Quénum C; Dhumeaux D; Benhamou JP
    Gastroenterol Clin Biol; 1983 Oct; 7(10):761-9. PubMed ID: 6628910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver.
    Laharie D; Vergniol J; Bioulac-Sage P; Diris B; Poli J; Foucher J; Couzigou P; Drouillard J; de Lédinghen V
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):487-93. PubMed ID: 19940782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
    Ferlitsch A; Teml A; Reinisch W; Ulbrich G; Wrba F; Homoncik M; Gangl A; Peck-Radosavljevic M; Vogelsang H
    Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodular regenerative hyperplasia of the liver in renal transplantation.
    Morales JM; Prieto C; Colina F; Mestre MJ; Lopez I; Perez-Sola A; Solis Herruzo JA; Ruilope LM; Rodicio JL
    Transplant Proc; 1987 Oct; 19(5):3694-6. PubMed ID: 3313894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?
    Gilissen LP; Derijks LJ; Driessen A; Bos LP; Hooymans PM; Stockbrügger RW; Engels LG
    Dig Liver Dis; 2007 Feb; 39(2):156-9. PubMed ID: 17188950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
    Calabrese E; Hanauer SB
    J Crohns Colitis; 2011 Feb; 5(1):48-53. PubMed ID: 21272804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Portal hypertension without liver cirrhosis in renal transplant recipients.
    Olsen TS; Fjeldborg O; Hansen HE
    APMIS Suppl; 1991; 23():13-20. PubMed ID: 1883637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Turner syndrome and nodular regenerative hyperplasia of the liver].
    Thevenot T; Dhote R; Tulliez M; Baverel F; Permal S; Rabineau D; Christoforov B
    Ann Med Interne (Paris); 1998 Sep; 149(5):295-6. PubMed ID: 9791565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nodular regenerative hyperplasia of the liver. Report of three cases and review of the literature.
    Mones JM; Saldana MJ; Albores-Saavedra J
    Arch Pathol Lab Med; 1984 Sep; 108(9):741-3. PubMed ID: 6547828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology of the liver in "idiopathic portal hypertension" associated with autoimmune disease. The Ministry of Health and Welfare Disorders of Portal Circulation Research Committee.
    Nakanuma Y; Nonomura A; Hayashi M; Doishita K; Takayanagi N; Uchida T; Obata Y; Noma K; Ikoma J; Yoshikawa K
    Acta Pathol Jpn; 1989 Sep; 39(9):586-92. PubMed ID: 2596298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Portal hypertension and nodular regenerative hyperplasia in a patient with celiac disease.
    Biecker E; Trebicka J; Fischer HP; Sauerbruch T; Lammert F
    Z Gastroenterol; 2006 May; 44(5):395-8. PubMed ID: 16688657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodular regenerative hyperplasia of the liver graft after liver transplantation.
    Gane E; Portmann B; Saxena R; Wong P; Ramage J; Williams R
    Hepatology; 1994 Jul; 20(1 Pt 1):88-94. PubMed ID: 8020909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nodular regenerative hyperplasia causing portal hypertension in a patient with chronic graft versus host disease: response to sirolimus.
    Choe H; Aldoss I; Chaudhary P; Donovan J; Petrovic L; Pullarkat V
    Acta Haematol; 2014; 132(1):49-52. PubMed ID: 24434665
    [No Abstract]   [Full Text] [Related]  

  • 37. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome.
    Maida I; Garcia-Gasco P; Sotgiu G; Rios MJ; Vispo ME; Martin-Carbonero L; Barreiro P; Mura MS; Babudieri S; Albertos S; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):103-7. PubMed ID: 18389904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nodular regenerative hyperplasia of the liver associated with idiopathic membranous glomerulonephritis.
    Haratake J; Horie A; Takasugi M; Hiroshige K
    Am J Gastroenterol; 1987 Jul; 82(7):677-80. PubMed ID: 3605029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.
    Malamut G; Ziol M; Suarez F; Beaugrand M; Viallard JF; Lascaux AS; Verkarre V; Bechade D; Poynard T; Hermine O; Cellier C
    J Hepatol; 2008 Jan; 48(1):74-82. PubMed ID: 17998147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.